Literature DB >> 7821739

Short-term regulation of glucokinase.

E Van Schaftingen1.   

Abstract

The activity of liver glucokinase is controlled in the short term by the concentration of its substrate glucose and by a regulatory protein, which acts as a competitive inhibitor with respect to glucose. In mammalian species, the effect of this protein is modulated by fructose 6-phosphate, which reinforces the inhibition, and by fructose 1-phosphate which antagonizes it. In the rat, the regulatory protein is found in the two tissues that express glucokinase, i.e., the liver and the pancreatic islets. Of particular interest is the fact that the regulatory protein is absent from the liver in those species that have no hepatic glucokinase. These results indicate that the two proteins form a functional unit. The regulatory protein appears in rat liver before birth, whereas glucokinase is only synthesized after 15 days of extrauterine life. The concentration of regulatory protein in the liver of the adult rat decreases by about 50% during starvation and in diabetes mellitus. Under these conditions, the difference between the concentrations of regulatory protein and glucokinase remains constant at about 0.4-0.5 nmol/g.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7821739     DOI: 10.1007/bf00400825

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  20 in total

1.  The mechanism by which rat liver glucokinase is inhibited by the regulatory protein.

Authors:  A Vandercammen; E Van Schaftingen
Journal:  Eur J Biochem       Date:  1990-07-31

Review 2.  Regulation of glucokinase in liver.

Authors:  S Weinhouse
Journal:  Curr Top Cell Regul       Date:  1976

3.  Cloning and sequencing of rat liver cDNAs encoding the regulatory protein of glucokinase.

Authors:  M Detheux; J Vandekerckhove; E Van Schaftingen
Journal:  FEBS Lett       Date:  1993-04-26       Impact factor: 4.124

4.  The amino acid sequence of rat liver glucokinase deduced from cloned cDNA.

Authors:  T L Andreone; R L Printz; S J Pilkis; M A Magnuson; D K Granner
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

5.  A protein from rat liver confers to glucokinase the property of being antagonistically regulated by fructose 6-phosphate and fructose 1-phosphate.

Authors:  E Van Schaftingen
Journal:  Eur J Biochem       Date:  1989-01-15

6.  The inhibition of rat liver glucokinase by palmitoyl-CoA.

Authors:  C M Dawson; C N Hales
Journal:  Biochim Biophys Acta       Date:  1969-04-29

Review 7.  Glucokinase and candidate genes for type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  P J Randle
Journal:  Diabetologia       Date:  1993-04       Impact factor: 10.122

8.  Specific inhibition of glucokinase by long chain acyl coenzymes A below the critical micelle concentration.

Authors:  P S Tippett; K E Neet
Journal:  J Biol Chem       Date:  1982-11-10       Impact factor: 5.157

Review 9.  Mechanism of liver glucokinase.

Authors:  D Pollard-Knight; A Cornish-Bowden
Journal:  Mol Cell Biochem       Date:  1982-04-30       Impact factor: 3.396

10.  Palmitate inhibits liver glycolysis. Involvement of fructose 2,6-bisphosphate in the glucose/fatty acid cycle.

Authors:  L Hue; L Maisin; M H Rider
Journal:  Biochem J       Date:  1988-04-15       Impact factor: 3.857

View more
  15 in total

1.  Involvement of glucokinase translocation in the mechanism by which resorcinol inhibits glycolysis in hepatocytes.

Authors:  L Agius
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

2.  Long-term maintenance of low concentrations of fructose for the study of hepatic glucose phosphorylation.

Authors:  J W Phillips; M N Berry
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

3.  Decreased glucokinase protein expression in the aged gerbil hippocampus.

Authors:  Choong Hyun Lee; Joon Ha Park; Moo-Ho Won
Journal:  Cell Mol Neurobiol       Date:  2013-03-21       Impact factor: 5.046

Review 4.  A fresh view of glycolysis and glucokinase regulation: history and current status.

Authors:  Sigurd Lenzen
Journal:  J Biol Chem       Date:  2014-03-17       Impact factor: 5.157

5.  Conformational transition pathway in the allosteric process of human glucokinase.

Authors:  Jian Zhang; Chenjing Li; Kaixian Chen; Weiliang Zhu; Xu Shen; Hualiang Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

6.  Investigation of the mechanism by which glucose analogues cause translocation of glucokinase in hepatocytes: evidence for two glucose binding sites.

Authors:  L Agius; M Stubbs
Journal:  Biochem J       Date:  2000-03-01       Impact factor: 3.857

7.  Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin.

Authors:  Mary C Sugden; Karen Bulmer; Geoffrey F Gibbons; Brian L Knight; Mark J Holness
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

8.  Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects.

Authors:  Claudia Ha Ting Tam; Janice Sin Ka Ho; Ying Wang; Heung Man Lee; Vincent Kwok Lim Lam; Soren Germer; Mitchell Martin; Wing Yee So; Ronald Ching Wan Ma; Juliana Chung Ngor Chan; Maggie Chor Yin Ng
Journal:  PLoS One       Date:  2010-07-08       Impact factor: 3.240

9.  Time-course changes in immunoreactivities of glucokinase and glucokinase regulatory protein in the gerbil hippocampus following transient cerebral ischemia.

Authors:  Joon Ha Park; Choong Hyun Lee; In Hye Kim; Ji Hyeon Ahn; Jeong-Hwi Cho; Bing Chun Yan; Jae-Chul Lee; Tae Hun Lee; Jeong Yeol Seo; Jun Hwi Cho; Moo-Ho Won; Il-Jun Kang
Journal:  Neurochem Res       Date:  2013-10-22       Impact factor: 3.996

10.  Lys169 of human glucokinase is a determinant for glucose phosphorylation: implication for the atomic mechanism of glucokinase catalysis.

Authors:  Jian Zhang; Chenjing Li; Ting Shi; Kaixian Chen; Xu Shen; Hualiang Jiang
Journal:  PLoS One       Date:  2009-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.